Biotech News

Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences

Madrigal (MDGL)MadrigalCompany update

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences:

Related news

Madrigal

MASH-Focused Biopharmaceutical Company Madrigal Pharmaceuticals is focused on metabolic dysfunction-associated steatohepatitis, a progressive liver disease that can lead to cirrhosis, liver failure, cancer, and transplantation. The company is building a specialized commercial and clinical-development organization around therapies that...

Recent company news

Stock data

Close
396.74 USD
Market cap
10.44B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States